Inc. XZeal Technologies

XZeal Technologies, Inc.
Product: XZeal Dental X-Ray Unit Z70
Date: 2/20/2015

1. Failure to establish and maintain procedures for validating the device design, as required by 21 CFR 820.30(g). For example:
b. Your firm has not established and maintained documentation in support of Section 4.6 – Design Validation of the Product – Conception and Development, PR0-04.01, Ver. 00, concerning software validation of the embedded software for the device. Specifically, you stated to our investigator that your firm is not responsible for the software because your firm does not manufacture it. You also stated to our investigator your firm did not know what, if any, validation activities were performed by your firm?s Chinese supplier for this software.

In addition, your firm?s Risk Analysis Report ? Software, Ver. 00, Technical File, does not adequately access the risk presented by the software controlling the XZeal Dental X-Ray Unit Z70 as a moderate risk to users and patients. For example, the report indicates a ?No? to the questions: ?Could a malfunction of, or a latent design flaw in the Software Device lead to an erroneous diagnosis or a delay in delivery of appropriate medical care that would likely lead to Moderate Injury? and ?Does the Software Device control the delivery of potentially harmful energy that could result in death or serious injury, such as radiation treatment systems, defibrillators and ablation generators.?

Your firm?s October 7, 2014 response includes reference to assembly operational checks or functional (Black-box) testing of the XZeal Dental X-Ray Unit Z70. Adequate software validation of the XZeal Dental X-Ray Unit Z70 software would require more than functional testing, including but not limited to a description of software (i.e.: Title, Manufacturer, Version Level, Release Date, etc.); control of capabilities of end user; reliability of functionality; maintenance and control of software versions; and adequate software hazard analysis.

FDA District Office: Florida District

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.